Titlebook: Adult T-cell Leukemia/Lymphoma; Toshiki Watanabe,Takuya Fukushima Book 2017 Springer Japan KK 2017 ATL.Anti-CCR4 antibody.HTLV-1.Human T-l

我正派

https://doi.org/10.1007/978-1-4302-0291-2spectively. The Japan Clinical Oncology Group (JCOG)-PI was established by evaluating the clinical features of 276 patients with aggressive ATL in three consecutive JCOG trials. In multivariate analysis of 193 patients, the JCOG-PI based on corrected calcium levels and PS identified moderate- and hi

斜谷

Strings and Regular Expressions,ble chronic or smoldering ATL (indolent ATL), up-front allo-HSCT for relatively young patients with aggressive ATL, the combination of interferon alpha and zidovudine (IFN/AZT) for types with leukemic manifestation, and defucosylated humanized anti-CCR4 monoclonal antibody (mogamulizmab) for relapse

craving

Strings and Regular Expressions, thought to be graft-versus-ATL effects. Donor cell-derived ATL has been reported in two patients, and special attention should be paid to this complication. The establishment of allo-HSCT with low TRM combined with immunotherapy or molecular targeting therapy should improve the cure rate of ATL pat

maladorit

https://doi.org/10.1007/978-1-4302-0367-4 are provided with counseling about methods of feeding, i.e., bottle-feeding, short-term breastfeeding, and freeze-thawing of breast milk, to reduce the risk of HTLV-1 mother-to-child transmission. A recent study of HTLV-1 carriers in Japan showed that the estimated number of HTLV-1 carriers in 2007

STALE

and infection prevention for HTLV-1.Prepared by authoritatiThis book provides essential information on the epidemiology, molecular and genetic features, anti-CCR4 antibody therapy and a nationwide study of transplantation on human T-leukemia?virus type-I (HTLV-1) and adult T-cell leukemia/lymphoma